Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 33Active not recruiting 8Terminated 6Unknown 4Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 51OTHER_GOV 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Injections 36Carboplatin 31Paclitaxel 24Docetaxel 24Capecitabine 24Gemcitabine 22Cisplatin 22pembrolizumab 21Oxaliplatin 21Bevacizumab 20Pemetrexed 18Fluorouracil 13Irinotecan 12Cyclophosphamide 11Nivolumab 8osimertinib 7Topotecan 7Leucovorin 7Dexamethasone 7toripalimab 6tislelizumab 6regorafenib 6lenvatinib 6fludarabine 6Trastuzumab 6Doxorubicin 6Cetuximab 6130-nm albumin-bound paclitaxel 6venetoclax 5Temozolomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Surgical Procedures, Operative × Clear all
NCT02448173 2026-02-02

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

Vaccinogen Inc

Phase 3 Not yet recruiting
550 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡